News from sorrento therapeutics, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:VPHM,NASDAQ-NMS:HALO)

Jun 06, 2013, 05:00 ET

Sorrento Therapeutics Receives Frost & Sullivan's 2013 Global Investment Opportunity Award in Oncology

 Sorrento Therapeutics, Inc. (OTCBB: SRNE) today announced that it has been awarded the 2013 Frost & Sullivan Global Investment Opportunity...

May 30, 2013, 20:15 ET

Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City

Sorrento Therapeutics (OTCBB: SRNE; or STI) today announced that Henry Ji, Ph.D., the Company's President and Chief Executive Officer, will present...

May 28, 2013, 05:00 ET
May 17, 2013, 16:29 ET

Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases

 Sorrento Therapeutics, Inc. (OTCBB: SRNE; or STI) announced today that its Fast-Track Advanced Technology Small Business Technology Transfer...

May 13, 2013, 16:00 ET

Sorrento Therapeutics, Inc. and IGDRASOL Announce the Acquisition of Exclusive Distribution Rights to Cynviloq™ for the European Union

 Sorrento Therapeutics, Inc. ("STI"; SRNE) and IGDRASOL announced today the acquisition of exclusive distribution rights from Samyang...

Apr 08, 2013, 00:17 ET

Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain

Sorrento Therapeutics, Inc. ("STI"; SRNE) and IGDRASOL announced today that IGDRASOL will be presenting updates of its analysis of proprietary late...

Mar 31, 2013, 22:05 ET

Sorrento Therapeutics, Inc. and IGDRASOL Announce Three Presentations on Cynviloq™ (IG-001; paclitaxel polymeric micelle) at the American Association of Cancer Research (AACR) Meeting

 Sorrento Therapeutics, Inc. ("STI"; SRNE) and IGDRASOL announced today that IGDRASOL will be presenting updates of its development of...

Mar 07, 2013, 06:17 ET

Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL

 Sorrento Therapeutics, Inc. ("STI"; SRNE: OB) today announced that it has signed an exclusive option to acquire IGDRASOL, a private company...

Jan 08, 2013, 06:00 ET

Sorrento Therapeutics acquires rights to produce recombinant intravenous immunoglobulins (rIVIG)

 Sorrento Therapeutics, Inc. (STI; OTCBB: SRNE) today announced that it has acquired worldwide rights that will allow for the application of...

Jun 07, 2012, 20:40 ET

Sorrento Therapeutics Awarded Third Phase I STTR Grant

Sorrento Therapeutics, Inc. (OTCBB: SRNE) today announced that it has received an Advanced Technology Small Business Technology Transfer Research...

Jul 28, 2011, 20:44 ET

Sorrento Therapeutics Awarded Phase I STTR Grant for C. difficile Program

Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) announced today that it has received a Phase I Small Business Technology Transfer Research...

Jul 01, 2011, 18:04 ET

Sorrento Therapeutics' Innovative Approach to Developing Vaccines and Therapeutics for MRSA Receives Continued Support From the National Institute of Allergy and Infectious Diseases

Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology...

May 21, 2010, 06:00 ET

Sorrento Therapeutics Awarded NIH Grant for MRSA Program

Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has received an Advanced Technology Small Business Technology...

Apr 14, 2010, 06:00 ET

Sorrento Therapeutics Announces Completion of Diverse Library of Full-Length, Fully Human Antibodies

Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced that it has completed the construction of an extensive library of...

Jan 11, 2010, 08:00 ET

Sorrento Therapeutics Announces Antibody Discovery and Development Alliance for the Prevention and Treatment of MRSA Infections

Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced an antibody discovery and development collaboration with The Scripps...

Oct 27, 2009, 08:00 ET

Sorrento Therapeutics Announces the Appointment of Martina Molsbergen as Vice President, Business Development

Sorrento Therapeutics, Inc. announced today that Martina Molsbergen has joined the Company as Vice President, Business Development. Ms....

Sep 21, 2009, 08:30 ET

Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger

Sorrento Therapeutics, Inc. ("STI"), a privately-held and development-stage biopharmaceutical company with a proprietary technology platform for...

Sep 18, 2009, 17:15 ET

Sorrento Therapeutics, Inc. and QuikByte Software, Inc. Complete Merger

Sorrento Therapeutics, Inc. ("STI"), a privately-held and development-stage biopharmaceutical company with a proprietary technology platform for...